SynopsisThe global market for ELISpot and FluoroSpot Assay was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 710 million by 2031, growing at a CAGR of 13.8% during the forecast period. The enzyme-linked immune absorbe.....
SynopsisThe global market for Pediatricians was valued at US$ 175910 million in the year 2024 and is projected to reach a revised size of US$ 235230 million by 2031, growing at a CAGR of 4.3% during the forecast period. Pediatrics is the branch of medicine that .....
SynopsisThe global market for Flu Vaccine was valued at US$ 8955 million in the year 2024 and is projected to reach a revised size of US$ 12990 million by 2031, growing at a CAGR of 5.5% during the forecast period. Influenza vaccines, also known as flu shots, ar.....
SynopsisThe global market for Actigraphy Sensors and Polysomnography Devices was valued at US$ 1458 million in the year 2024 and is projected to reach a revised size of US$ 2096 million by 2031, growing at a CAGR of 5.4% during the forecast period. An actigraph,.....
SynopsisThe global market for Intraoral Scanner was valued at US$ 472 million in the year 2024 and is projected to reach a revised size of US$ 861 million by 2031, growing at a CAGR of 9.1% during the forecast period. Intra Oral Scanners are one of the most exci.....
SynopsisThe global market for Enteral Feeding Devices was valued at US$ 3404 million in the year 2024 and is projected to reach a revised size of US$ 5316 million by 2031, growing at a CAGR of 6.7% during the forecast period. Enteral feeding device is a medical .....
SynopsisThe global market for Clear-Aligner Treatment was valued at US$ 5055 million in the year 2024 and is projected to reach a revised size of US$ 19630 million by 2031, growing at a CAGR of 21.7% during the forecast period. Clear-Aligner Treatment is orthodo.....
SynopsisThe global market for Empagliflozin Drug was valued at US$ 19490 million in the year 2024 and is projected to reach a revised size of US$ 51550 million by 2031, growing at a CAGR of 15.7% during the forecast period. Empagliflozin is an oral antidiabetic .....
SynopsisThe global market for Lenalidomide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. Lenalidomide, sold under the trade name Revlimid among others.....
SynopsisThe global market for Dry Eye Drugs was valued at US$ 10740 million in the year 2024 and is projected to reach a revised size of US$ 23500 million by 2031, growing at a CAGR of 12.0% during the forecast period. Dry eye syndrome (DES), also known as kerat.....
